Merck Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA RAHWAY, N.J., April 29, 2025--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD ...

This story was originally published on Manufacturing Dive. To receive daily news and insights, subscribe to our free daily Manufacturing Dive newsletter. Merck is constructing a $1 billion drug ...

New Jersey-based pharmaceutical giant Merck is investing $1 billion in what company executives described as a continued commitment to growing investments in United States manufacturing and jobs. Merck ...

Merck is investing $1 billion to build a U.S. plant in Delaware, in a show of its commitment to domestic manufacturing. The move comes amid plans by President Trump to impose tariffs on ...

(RTTNews) - Merck & Co., Inc. (MRK), Tuesday announced that the company has started construction of state-of-the-art biologics center of excellence worth $1 billion in Wilmington, Delaware, creating ...

Merck (NYSE:MRK) has broken ground on a $1 billion facility in Wilmington, Delaware, becoming the latest pharmaceutical company to boost domestic investment as industry-targeted tariffs loom. This 470 ...

"Merck is threatening to exploit that invention," known as immunotherapy, with a later-developed method of treatment, in violation of a May 20 patent, Bristol-Myers said in a lawsuit filed yesterday ...

Merck (MRK) Wilmington Biotech will serve as a launch and commercial production facility and the future U.S. home for KEYTRUDA A cornerstone of Merck’s continued commitment to investing in American ...

Merck, known as MSD outside of the United States and Canada, announced the start of construction for a $1 billion, 470,000-square-foot state-of-the-art biologics center of excellence in Wilmington, ...